The Company intends to use the net proceeds from the offering to fund commercialization activities for Mydcombi and clobetasol propionate, complete the CHAPERONE pediatric myopia clinical study, and ...

I didn’t want to be prescribed my previous go-to ointment: clobetasol propionate. It’s a powerful topical steroid that did an excellent job of curbing and eliminating flare-ups over the years. The ...

ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, ...

Eczema (also known as dermatitis) is a condition that primarily affects the skin, causing dryness, itchiness, scaliness, rashes, and blisters. In some cases, eczema can lead to skin infections. While ...

Alumis, a recent IPO, has ESK-001, a promising phase 3 TYK2 inhibitor for Psoriasis and SLE, showing superior efficacy and safety over existing treatments. ESK-001's allosteric inhibition offers high ...

EDMONTON, Alberta, Sept. 26, 2024 (GLOBE NEWSWIRE) -- MADD Canada is excited to invite the media to a special screening for the launch of the 2024-2025 National School Program sponsored by KAG Canada.